Patients with advanced lung cancer who receive a certain therapy earlier in the day survive longer, a study has found, with a Hong Kong medical expert saying the discovery opens possibilities for optimal treatment times although more research is needed.
The study was led by academics from Hunan Cancer Hospital in mainland China and supported by the Chinese University of Hong Kong’s faculty of medicine.
The research showed that immunochemotherapy administered before 3pm nearly doubled the length…
Patients given more hope as study finds best time for lung cancer treatment
